Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by Wino115on Mar 05, 2021 1:27pm
103 Views
Post# 32729527

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Maybe partnerships are coming soon

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Maybe partnerships are coming soonLet's give them a chance and watch. IR said they understand this and mgmt have said this is their year to execute on all cylinders.  We here have always argued that part of an overall corporate strategy includes a capital markets strategy. Obviously down the ladder compared to the products, trials, science; but it has to be there. We have seen small signs of it.  Let's see if they magnify the efforts --especially once they have that foundational data to really push their points. 

scarlet1967 wrote: I agree they have started attending more conferences but as per Spceo I also would like to see them utilizing  more retail oriented platforms like fire chat, drbeen.. so they get a balanced exposure among both institutional and retail investors. Institutions and their clients surely can increase the demand same applies to retail investors.
Wino115 wrote: I do believe this will change -- Conferences, AACR, maybe some of that data Qwerty speculated about the other day (?), first dose into human, safety, POC, etc...  We're all upset that this didn't participate and we could have used the money elsewhere and done quite well with all sorts of other investments.  I'm hopeful this year will be their year in the sun when others are getting stalled out given 2020 returns. Hard Data in Humans!  We need it. 

scarlet1967 wrote: My problem is TH never participated in the rally , they came out with NASH hiv followed by many encouraging preclinical oncology results followed by new skillful CEO followed by general NASH followed by record breaking sales and FDA's letters study may proceed for both programs etc .yet they are following the pack loosing "market valuation" which never gained any traction during the bull market despite all the catalysts/progresses. They have achieved many milestones and failed so far on one milestone which is selling the company to the market.
Other companies have produced  less good results but managed to get credit for the little things they have done which is the opposite scenario where TH has so far done.
They need to understand regardless where you are in your process you need to promote it because otherwise other companies will run you over, rub your audience and leave you with left overs.


juniper88 wrote:
Bucknelly21 wrote: Well wino there's the sub three you were worried about....


The TSX Venture index is down over 6% today, similar to yesterday. 

So, companies like TH are down...

 

 




<< Previous
Bullboard Posts
Next >>